CGBIO Co., Ltd.. is a total healthcare provider with a goal of enhancing the quality of life by offering range of innovative solutions for the spectrum of spinal disorders and wound management. Through extensive research activity, CGBIO is a leading manufacturer and distributor of comprehensive portfolio of allograft and synthetic bone grafts, spinal implants, GMP grade growth factors and total wound care solution. CG Bio has state of the art facility with class 100 clean rooms, purified water system fit for human injection and qualified technicians.
Looking for a particular CGBIO employee's phone or email?
CGBIO Questions
The CGBIO annual revenue was $17.9 million in 2026.
Aviva Park is the Director for development center in CGbio of CGBIO.
71 people are employed at CGBIO.
CGBIO is based in Seongnam, Ulsan.
The NAICS codes for CGBIO are [62111, 621111, 6211, 621, 62].
The SIC codes for CGBIO are [80, 801].
Top CGBIO Employees
-
Janghyun Baek
Vascular Business VP at CGBIO
Incheon, South Korea2 -
Steven Reinecke
Consultant: at CGBIO
Laguna Beach, CA, US24 -
2
-
Minseo Park
Product Manager at CGBIO
South Korea1 -
Matthew Kim
Team Lead Manager at CGBIO
South Korea1 -
광희 이
Global Strategy TF Leader at CGBIO
Yongin-si, KR1
Related Companies
